ES546884A0 - Un procedimiento para preparar un derivado de 7-(2-(dialqui-lamino)-etil)-4-hidroxi-1,3-bencimidazol-2-ona - Google Patents

Un procedimiento para preparar un derivado de 7-(2-(dialqui-lamino)-etil)-4-hidroxi-1,3-bencimidazol-2-ona

Info

Publication number
ES546884A0
ES546884A0 ES546884A ES546884A ES546884A0 ES 546884 A0 ES546884 A0 ES 546884A0 ES 546884 A ES546884 A ES 546884A ES 546884 A ES546884 A ES 546884A ES 546884 A0 ES546884 A0 ES 546884A0
Authority
ES
Spain
Prior art keywords
dialqui
bencimidazole
hidroxi
etil
lamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES546884A
Other languages
English (en)
Other versions
ES8605491A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of ES8605491A1 publication Critical patent/ES8605491A1/es
Publication of ES546884A0 publication Critical patent/ES546884A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES546884A 1984-09-12 1985-09-11 Un procedimiento para preparar un derivado de 7-(2-(dialqui-lamino)-etil)-4-hidroxi-1,3-bencimidazol-2-ona Expired ES8605491A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/649,465 US4554287A (en) 1984-09-12 1984-09-12 Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones

Publications (2)

Publication Number Publication Date
ES8605491A1 ES8605491A1 (es) 1986-03-16
ES546884A0 true ES546884A0 (es) 1986-03-16

Family

ID=24604906

Family Applications (1)

Application Number Title Priority Date Filing Date
ES546884A Expired ES8605491A1 (es) 1984-09-12 1985-09-11 Un procedimiento para preparar un derivado de 7-(2-(dialqui-lamino)-etil)-4-hidroxi-1,3-bencimidazol-2-ona

Country Status (12)

Country Link
US (1) US4554287A (es)
EP (1) EP0175525B1 (es)
JP (1) JPS6168473A (es)
AT (1) ATE53025T1 (es)
AU (1) AU586187B2 (es)
CA (1) CA1255685A (es)
DE (1) DE3577849D1 (es)
DK (1) DK407885A (es)
ES (1) ES8605491A1 (es)
GR (1) GR852189B (es)
PT (1) PT81109B (es)
ZA (1) ZA856943B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586123D1 (de) * 1984-08-15 1992-07-02 Schering Ag Neue dopamin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3728695A1 (de) * 1987-08-25 1989-03-09 Schering Ag Neue benzimidazol-derivate
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
TW356468B (en) * 1995-09-15 1999-04-21 Astra Pharma Prod Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
GB9526511D0 (en) * 1995-12-23 1996-02-28 Astra Pharma Prod Pharmaceutically active compounds
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
WO2009154557A1 (en) 2008-06-18 2009-12-23 Astrazeneca Ab Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070478A (en) * 1977-02-17 1978-01-24 Merck & Co., Inc. Benzimidazole substituted alanines
US4179505A (en) * 1977-03-30 1979-12-18 Janssen Pharmaceutica N.V. 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives
CA1108619A (en) * 1977-08-12 1981-09-08 Carl H. Ross 4-hydroxy-2-benzimidazolinone derivatives and the preparation thereof
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones

Also Published As

Publication number Publication date
US4554287A (en) 1985-11-19
DE3577849D1 (de) 1990-06-28
ATE53025T1 (de) 1990-06-15
JPS6168473A (ja) 1986-04-08
ZA856943B (en) 1986-06-25
GR852189B (es) 1986-01-10
PT81109B (en) 1987-07-06
CA1255685A (en) 1989-06-13
EP0175525B1 (en) 1990-05-23
ES8605491A1 (es) 1986-03-16
DK407885A (da) 1986-03-13
DK407885D0 (da) 1985-09-06
AU4714485A (en) 1986-03-20
PT81109A (en) 1985-10-01
EP0175525A1 (en) 1986-03-26
AU586187B2 (en) 1989-07-06

Similar Documents

Publication Publication Date Title
NO854941L (no) Fremgangsmaate for fremstilling av terapeutisk aktive, sure indol-derivater.
ES8700663A1 (es) Un procedimiento para preparar un derivado de 1,3-benzotia- zol-2(3h)-ona o 1,3-benzoxazol-2(3h)-ona
ES499870A0 (es) Un procedimiento para la preparacion de derivados de indano
SE8602723L (sv) Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem
ES539446A0 (es) Un procedimiento para preparar un derivado de dihidropiridazinona
ES546884A0 (es) Un procedimiento para preparar un derivado de 7-(2-(dialqui-lamino)-etil)-4-hidroxi-1,3-bencimidazol-2-ona
ES542125A0 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina.
ES524680A0 (es) Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
ES528561A0 (es) Un procedimiento para la preparacion de compuestos nitro alifaticos
ES547620A0 (es) Procedimiento para preparar pirazol (3,4-b) piridinamidas.
FI853763A0 (fi) 1,3-dimetyl-1h-purin-2,6-dioner, som innehaoller 1h-indol-3-yl.
ES545775A0 (es) Un procedimiento para preparar un derivado de vinilisoquino-linas
ES521440A0 (es) Un procedimiento para preparar derivados de imidazolina.
ES534858A0 (es) Procedimiento para la obtencion de derivados de 1-(4'-alquiltiofenil)-2-amino-1,3-propandiol
ES509154A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido &-glutamil-diaminopimelilo.